Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Evaluation of Social-software Improving Warfarin Therapy in Patients With Mechanical Heart Valve Replacement

NCT03264937 is registered in ClinicalTrials.gov with Wuhan Asia Heart Hospital as lead sponsor.

NCT NCT03264937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03264937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Evaluation of Social-software Improving Warfarin Therapy in Patients With Mechanical Heart Valve Replacement
Lead sponsor
Wuhan Asia Heart Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2017
Completion date
March 8, 2019
Enrollment
735 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants causing adverse effects in therapeutic use, patient compliance